EMA and EUnetHTA Launch Joint Gateway for Parallel Advice

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency and the European Network for Health Technology Assessment developed a joint platform for parallel consultations on evidence plans for marketing authorizations and health technology assessments to provide sponsors with simultaneous, coordinated advice on development strategies.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor